Seer, Inc.
SEERNASDAQHealthcareBiotechnology

About Seer

Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Company Information

CEOOmid Farokhzad
Founded2017
IPO DateDecember 4, 2020
Employees134
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock
Share ClassClass A Shares

Contact Information

Websiteseer.bio
Phone650 453 0000
Address
3800 Bridge Parkway, Suite 102 Redwood City, California 94065 United States

Corporate Identifiers

CIK0001726445
CUSIP81578P106
ISINUS81578P1066
EIN82-1153150
SIC3826

Leadership Team & Key Executives

Dr. Omid C. Farokhzad M.D., Ph.D.
Founder, Chief Executive Officer, and Chair of the Board of Directors
David R. Horn
President,Treasurer and Chief Financial Officer
Kenny Ross
Chief Operations and Product Officer
Marissa Dixon
Chief People Officer
Dr. Serafim Batzoglou Ph.D.
Chief Data Officer
Martin Goldberg Ph.D.
Senior Vice President of Product Development
Dr. Asim Siddiqui Ph.D.
Senior Vice President of Research and Tech Development